Identification of Novel Candidate Genes for Treatment Response to Risperidone and Susceptibility for Schizophrenia: Integrated Analysis Among Pharmacogenomics, Mouse Expression, and Genetic Case-Control Association Approaches
Masashi Ikeda(Fujita Health University), Nakao Iwata(Fujita Health University), Norio Ozaki(Nagoya University), Akihiro Mouri(Fujita Health University), Ryota Hashimoto(National Center of Neurology and Psychiatry), Yoshio Yamanouchi(National Center of Neurology and Psychiatry), Tadao Arinami(Japan Science and Technology Agency), Toshitaka Nabeshima(Fujita Health University), Tomo Okochi(Fujita Health University), Michael O‘Donovan(Cardiff University), Yoko Kinoshita(Japan Science and Technology Agency), Jun Nakamura(National Museum of Ethnology), Hiroyuki Honda(Nagoya University), Reiji Yoshimura(University of Occupational and Environmental Health Japan), Masatoshi Takeda(Osaka Kawasaki Rehabilitation University), Minori Koga(Japan Science and Technology Agency), Hywel Williams(Cardiff University), Yasuyuki Tomita(Nagoya University), Michael J. Owen(Cardiff University)
Cited by 97
Related Papers
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
|Nature Genetics|2013|2.4k
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder
|Nature Genetics|2008|1.3k
Schizophrenia
|Nature Reviews Disease Primers|2015|1.1k